Impact of proton pump inhibitors on clinical outcomes in patients after acute myocardial infarction: a propensity score analysis from China Acute Myocardial Infarction (CAMI) registry

BACKGROUND: Proton pump inhibitors (PPIs) are recommended by the latest guidelines to reduce the risk of bleeding in acute myocardial infarction (AMI) patients treated with dual antiplatelet therapy (DAPT). However, previous pharmacodynamic and clinical studies have reported controversial results on...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Geriatr Cardiol
Prif Awduron: SHI, Wen-Ce, GAO, Si-De, YANG, Jin-Gang, FAN, Xiao-Xue, NI, Lin, SU, Shu-Hong, YU, Mei, YANG, Hong-Mei, YU, Meng-Yue, YANG, Yue-Jin, on behalf of China Acute Myocardial In-farction (CAMI) Registry study group
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Science Press 2020
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7729183/
https://ncbi.nlm.nih.gov/pubmed/33343644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11909/j.issn.1671-5411.2020.11.008
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg